Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Imaging and Pathological Findings of Breast Cancer in Very Young Women: Report of a Twenty-Year Retrospective Study Publisher Pubmed



Sefidbakht S3 ; Beizavi Z1 ; Kanaani Nejad F2 ; Pishdad P3 ; Sadighi N4 ; Ghoddusi Johari M5 ; Bijan B6 ; Tahmasebi S5, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Radiology, Mayo Clinic, Phoenix, AZ, United States
  2. 2. Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Radiology Department, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Sutter Imaging (SMG) – Sacramento, Professor of Nuclear Medicine & Radiology (W.O.S.), University of California Davis Medical Center, Sacramento, CA, United States
  7. 7. Surgical Oncology Division, General Surgery Department, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Clinical Imaging Published:2024


Abstract

Purpose: In this study, we aimed to assess the new trends in characteristics, molecular subtypes, and imaging findings of breast cancer in very young women. Methods: We retrospectively reviewed the database of a primary breast cancer referral center in southern Iran in 342 cases of 30-year-old or younger women from 2001 to 2020. Pathologic data, including nuclear subtype and grade, tumor stage, presence of in situ cancer, imaging data including lesion type in mammogram and ultrasound, and treatment data were recorded. Descriptive statistics were applied. Differences between categorical values between groups were compared using Pearson's Chi-square test. Results: The mean age was 27.89 years. The tumor type was invasive ductal carcinoma in 82 % of cases. Fourteen patients (4.4 %) had only in situ cancer, and 170 patients had in situ components (49.7 %). Molecular subtypes were available in 278 patients, including 117 (42.1 %) Luminal A, 64 (23.0 %) Luminal B, 58 (20.9 %) triple negative, and 39 (14 %) HER2 Enriched. In those with mammograms available, 63 (30.1 %) had no findings, 53 (25.3 %) had mass, 27 (12.9 %) had asymmetry, whether focal or global, 21 (10 %) had microcalcifications solely, and 45 (21.5 %) had more than one finding. Microcalcifications were significantly more common in Luminal cancers than HER2 and triple-negative cancers (p = 0.041). Conclusion: Our study shows the most common subtype to be Luminal A cancer, with 74 % of the tumors being larger than 2 cm at the time of diagnosis. Irregular masses with non-circumscribed margins were the most common imaging findings. © 2024
Other Related Docs
12. Principles of Pharmacogenomics and Pharmacogenetics, Precision Medicine in Clinical Practice (2022)
24. The Epidemiology of Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
32. Long-Term Survival and Prognostic Factors of Breast Cancer, Archives of Iranian Medicine (2022)
38. Preterm Birth and Breast Cancer Risk: A Systematic Review and Meta-Analysis, Asian Pacific Journal of Cancer Prevention (2023)
44. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)
46. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
47. Direct and Indirect Medical Costs of Bladder Cancer in Iran, Cost Effectiveness and Resource Allocation (2023)